Omori, T., Endo, S., Yamaguchi, T., Miyagaki, H., Tanaka, R., Takahashi, N., Masuzawa, T., Furukawa, H., Sato, Y., Takeno, A., Shinno, N., Kawada, J., Kawabata, R., Katsuyama, S., Higashi, S., Kurokawa, Y., Tsujinaka, T., Shimokawa, T., Satoh, T. (2026). Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: Final outcomes of a multicenter, phase II study (OGSG1902).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.366